The Latest Headlines at Daily Political
Head-To-Head Review: Vertex Pharmaceuticals (NASDAQ:VRTX) vs. Celldex Therapeutics (NASDAQ:CLDX)
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) and Celldex Therapeutics (NASDAQ:CLDX – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based... More of this article »
Financial Analysis: Innovative Solutions and Support (NASDAQ:ISSC) & FTAI Aviation (NASDAQ:FTAI)
Innovative Solutions and Support (NASDAQ:ISSC – Get Free Report) and FTAI Aviation (NASDAQ:FTAI – Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based... More of this article »
Head to Head Review: Pluri (NASDAQ:PLUR) and Nurix Therapeutics (NASDAQ:NRIX)
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Pluri (NASDAQ:PLUR – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their... More of this article »
B. Riley Financial (NASDAQ:RILY) versus Blue Owl Capital (NYSE:OBDC) Head-To-Head Review
Blue Owl Capital (NYSE:OBDC – Get Free Report) and B. Riley Financial (NASDAQ:RILY – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength... More of this article »
Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease
Belite Bio (NASDAQ:BLTE) said the U.S. Food and Drug Administration has accepted its new drug application for tinlarebant as a treatment for Stargardt disease type 1, granted the application priority review and set a Feb. 12, 2027,... More of this article »
RxSight (NASDAQ:RXST) CFO Mark Wilterding Sells 7,765 Shares of Stock
RxSight, Inc. (NASDAQ:RXST – Get Free Report) CFO Mark Wilterding sold 7,765 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $6.96, for a total value... More of this article »
Lifecore Biomedical (NASDAQ:LFCR) versus Contineum Therapeutics (NASDAQ:CTNM) Head-To-Head Survey
Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses... More of this article »
Komatsu (KMTUY) and Its Competitors Financial Survey
Komatsu (OTCMKTS:KMTUY – Get Free Report) is one of 434 publicly-traded companies in the “Machinery” industry, but how does it weigh in compared to its peers? We will compare Komatsu to similar companies based on... More of this article »
Financial Analysis: CoreWeave (NASDAQ:CRWV) versus Nomura Research Institute (OTCMKTS:NRILY)
Nomura Research Institute (OTCMKTS:NRILY – Get Free Report) and CoreWeave (NASDAQ:CRWV – Get Free Report) are both large-cap technology companies, but which is the superior stock? We will compare the two companies based... More of this article »
Financial Comparison: Banzai International (NASDAQ:BNZI) vs. Trimble (NASDAQ:TRMB)
Trimble (NASDAQ:TRMB – Get Free Report) and Banzai International (NASDAQ:BNZI – Get Free Report) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength... More of this article »
Healthcare Triangle (NASDAQ:HCTI) and DarioHealth (NASDAQ:DRIO) Head to Head Comparison
DarioHealth (NASDAQ:DRIO – Get Free Report) and Healthcare Triangle (NASDAQ:HCTI – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based... More of this article »
Annovis Bio Targets March 2027 Alzheimer’s Readout, Prepares Rolling NDA
Annovis Bio (NYSE:ANVS) said it expects to report top-line results from the six-month portion of its pivotal Phase III Alzheimer’s disease trial in March 2027, while preparing a rolling new drug application, or NDA, that management... More of this article »
CAMP4 Therapeutics (NASDAQ:CAMP) CFO Purchases $39,600.00 in Stock
CAMP4 Therapeutics Corporation (NASDAQ:CAMP – Get Free Report) CFO Kelly Gold bought 10,000 shares of the stock in a transaction that occurred on Monday, August 31st. The shares were purchased at an average price of $3.96 per... More of this article »